Skip to main content
State Accountability Project
FOIA Number: HHS-FDA-19-1105
News Roundup: Trump’s Enthusiastic Support for New Drug Raises Questions
September 6, 2019
Investigating the administration's approval of Spravato, Trump's potential campaign-finance violations, and the promotion of Trump properties.
FOIA to FDA Seeking Email Communications with the White House Regarding the Anti-Depressant Nasal Spray Spravato
September 4, 2019
FOIA request to the U.S. Food & Drug Administration seeking email communications between FDA officials and the White House regarding the anti-depressant nasal spray Spravato (esketamine).
Help us keep the American Government accountable